ArticleOncotarget2015

Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status.

Martin Michaelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.